US FDA launches unified platform to report drug side effects

March 11 (Reuters) - The U.S. Food and Drug Administration said on Wednesday it has introduced a unified platform designed to streamline the analysis of reports on drug side effects. * The new platform, called FDA Adverse Event MonitoringSystem (AEMS), would include adverse-event reports submitted tothe U.S. health regulator for drugs, biologics, vaccines,cosmetics and animal food on a single,